What is the debt of Laboratory Corporation of America Holdings this year?
Laboratory Corporation of America Holdings has a debt level of 4,602.7 USD this year.
Laboratory Corporation of America Holdings Debt 2024
Laboratory Corporation of America Holdings Debt
4,602.7 USD
Ticker
LH
ISIN
US50540R4092
WKN
895308
In 2024, Laboratory Corporation of America Holdings's total debt was 4,602.7 USD, a -7.94% change from the 4,999.7 USD total debt recorded in the previous year.
Laboratory Corporation of America Holdings Aktienanalyse
What does Laboratory Corporation of America Holdings do?
The Laboratory Corporation of America Holdings, also known as LabCorp, is an American company that has been operating in the medical diagnostics industry since 1978. It was founded by a doctor and a laboratory scientist with the goal of simplifying and improving the diagnostic process. LabCorp is now the largest independent diagnostic company in the world, with over 60,000 employees. LabCorp's business model is to contribute to the prevention, diagnosis, and treatment of diseases through its comprehensive diagnostic services. The company offers a wide range of medical laboratory tests, clinical studies, and DNA analysis services. LabCorp operates more than 2,000 locations in the United States, Canada, and Europe, and provides its services worldwide. LabCorp is divided into three business segments: Diagnostics, Drug Development, and CRO (contract research organization). Under the Diagnostics segment, the company offers laboratory tests for clinical detection, cancer diagnosis, genetic testing, and more. The company specializes in blood, body fluid, and tissue analyses and also offers a variety of specialized tests to answer specific medical questions. LabCorp's Drug Development segment aims to accelerate and improve drug development through its comprehensive clinical studies. The company assists with study coordination and compliance with regulatory requirements to ensure accurate and reliable study results. LabCorp's CRO segment offers clinical study services, including study planning, design, execution, and analysis. This enables the company to develop groundbreaking treatment options for diseases that do not yet have adequate therapies. LabCorp is also heavily involved in the development of personalized diagnostics to provide patients with even more accurate diagnosis and treatment options. LabCorp offers a wide range of products. The company is a leading provider of clinical laboratory services and offers a broad range of laboratory tests for infections, hormonal disorders, autoimmune diseases, allergies, and cancer. Some of the specialized tests offered by LabCorp include genetic testing for cancer diagnosis and inherited metabolic disorders. In the Drug Development segment, the company offers a wide range of clinical studies aimed at developing new drugs and therapies. LabCorp also utilizes its DNA identification services to confirm the identity of individuals or assist in forensic cases. In summary, LabCorp is a successful company specialized in medical diagnostics. Over the past 40 years, the company has experienced impressive growth and positioned itself as a leading provider of clinical laboratory services. With its wide range of diagnostic services, clinical studies, and DNA identification services, LabCorp provides innovative solutions for the medical challenges of the future. Laboratory Corporation of America Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Laboratory Corporation of America Holdings's Debt Structure
Laboratory Corporation of America Holdings's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Laboratory Corporation of America Holdings's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Laboratory Corporation of America Holdings’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Laboratory Corporation of America Holdings’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Laboratory Corporation of America Holdings stock
What was the debt of Laboratory Corporation of America Holdings compared to the previous year?
The debt of Laboratory Corporation of America Holdings has increased by -7.94% compared to the previous year dropped.
What are the consequences of high debt for investors in Laboratory Corporation of America Holdings?
High debt can pose a risk for investors of Laboratory Corporation of America Holdings, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Laboratory Corporation of America Holdings?
Low debt means that Laboratory Corporation of America Holdings has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Laboratory Corporation of America Holdings affect the company?
An increase in debt of Laboratory Corporation of America Holdings can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Laboratory Corporation of America Holdings affect the company?
A reduction in debt of Laboratory Corporation of America Holdings can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Laboratory Corporation of America Holdings?
Some factors that can influence the debt of Laboratory Corporation of America Holdings include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Laboratory Corporation of America Holdings so important for investors?
The debts of Laboratory Corporation of America Holdings are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Laboratory Corporation of America Holdings take to change the debt?
To change the debt, Laboratory Corporation of America Holdings can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Laboratory Corporation of America Holdings pay?
Over the past 12 months, Laboratory Corporation of America Holdings paid a dividend of 2.88 USD . This corresponds to a dividend yield of about 1.3 %. For the coming 12 months, Laboratory Corporation of America Holdings is expected to pay a dividend of 3.19 USD.
What is the dividend yield of Laboratory Corporation of America Holdings?
The current dividend yield of Laboratory Corporation of America Holdings is 1.3 %.
When does Laboratory Corporation of America Holdings pay dividends?
Laboratory Corporation of America Holdings pays a quarterly dividend. This is distributed in the months of March, June, June, September.
How secure is the dividend of Laboratory Corporation of America Holdings?
Laboratory Corporation of America Holdings paid dividends every year for the past 7 years.
What is the dividend of Laboratory Corporation of America Holdings?
For the upcoming 12 months, dividends amounting to 3.19 USD are expected. This corresponds to a dividend yield of 1.44 %.
In which sector is Laboratory Corporation of America Holdings located?
Laboratory Corporation of America Holdings is assigned to the 'Health' sector.
Wann musste ich die Aktien von Laboratory Corporation of America Holdings kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Laboratory Corporation of America Holdings from 9/13/2024 amounting to 0.72 USD, you needed to have the stock in your portfolio before the ex-date on 8/29/2024.
When did Laboratory Corporation of America Holdings pay the last dividend?
The last dividend was paid out on 9/13/2024.
What was the dividend of Laboratory Corporation of America Holdings in the year 2023?
In the year 2023, Laboratory Corporation of America Holdings distributed 2.16 USD as dividends.
In which currency does Laboratory Corporation of America Holdings pay out the dividend?
The dividends of Laboratory Corporation of America Holdings are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Laboratory Corporation of America Holdings
Our stock analysis for Laboratory Corporation of America Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Laboratory Corporation of America Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Laboratory Corporation of America Holdings Revenue
- Laboratory Corporation of America Holdings Net Income
- Laboratory Corporation of America Holdings P/E
- Laboratory Corporation of America Holdings P/S
- Laboratory Corporation of America Holdings EBIT
- Laboratory Corporation of America Holdings Dividend
- Laboratory Corporation of America Holdings Stocks
- Laboratory Corporation of America Holdings Market capitalization
- Laboratory Corporation of America Holdings Debt
- Laboratory Corporation of America Holdings Liabilities
- Laboratory Corporation of America Holdings Equity
- Laboratory Corporation of America Holdings AAQS
- Laboratory Corporation of America Holdings Employees
- Laboratory Corporation of America Holdings ROE
- Laboratory Corporation of America Holdings ROA
- Laboratory Corporation of America Holdings ROCE
